- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06655909
Serum Ferritin Concentration in Kenyan Women and Their Preschool Children at Which the Body Begins to Upregulate Iron Absorption From the Diet
May 19, 2025 updated by: Isabelle Herter-Aeberli
Defining the Serum Ferritin Concentration in Kenyan Women and Their Preschool Children at Which the Body Senses Iron Depletion and Begins to Upregulate Iron Absorption From the Diet
Using standardized methods, the investigators will perform stable iron isotope absorption studies in young Kenyan women and their preschool children (2-5y of age) with varying iron status to measure iron absorption from maize meal containing labeled ferrous sulfate.
Using these data, this study aim is to define the ferritin in these young women and children at which the body senses iron depletion and begins to upregulate iron absorption from the diet; this approach could provide a functionally defined threshold of iron deficiency in Sub-Saharan African women and children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this experimental study in southern Kenya, the investigators will take a baseline venous blood sample to measure iron and inflammation biomarkers in generally healthy young women (n=125) and in their preschool children.
The investigators will then administer, after an overnight fast, a standardized test meal porridge made from refined maize and bottled water containing the stable iron isotope 57Fe.
Fourteen days later, the investigators will take a second venous blood sample for determination of erythrocyte incorporation of the 57Fe to measure iron absorption from the labeled test meal.
Study Type
Interventional
Enrollment (Actual)
275
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Msambweni, Kenya
- ETH/JKUAT Research Station
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- < 75 kg
- BMI between 17 - 27.5 kg/m2
- No acute illness (self-reported)
- No metabolic or gastrointestinal disorders (self-reported)
- No use of medication affecting iron absorption or metabolism during the study
- No intake of mineral/vitamin supplements 2 weeks prior to the first study visit and during study
- Mother of a preschool age child (2-5 years)
- Child has normal Z-scores for WAZ, HAZ and WHZ (-3 - +3)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: mothers
healthy volunteers
|
consumption of maize porridge containing stable iron isotope
|
|
Other: preschool children
healthy volunteers
|
consumption of maize porridge containing stable iron isotope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fractional iron absorption
Time Frame: Study day 14
|
Erythrocyte iron incorporation
|
Study day 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum ferritin
Time Frame: Study day 1
|
Serum ferritin concentration
|
Study day 1
|
|
soluble transferrin receptor
Time Frame: Study day 1
|
soluble transferrin receptor concentration in serum
|
Study day 1
|
|
C-reactive protein
Time Frame: Study day 1
|
C-reactive protein concentration in serum
|
Study day 1
|
|
alpha(1)-acid-glycoprotein
Time Frame: Study day 1
|
alpha(1)-acid-glycoprotein concentration in serum
|
Study day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2024
Primary Completion (Actual)
November 13, 2024
Study Completion (Actual)
November 13, 2024
Study Registration Dates
First Submitted
October 22, 2024
First Submitted That Met QC Criteria
October 22, 2024
First Posted (Actual)
October 24, 2024
Study Record Updates
Last Update Posted (Actual)
May 22, 2025
Last Update Submitted That Met QC Criteria
May 19, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MOCHA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
AbbVieRecruiting
-
AbbVieNot yet recruiting
-
Advenchen Laboratories Nanjing Ltd.Not yet recruitingHealthy VolunteerChina
-
Hinge BioRecruiting
-
HK inno.N CorporationNot yet recruitingHealthy VolunteerSouth Korea
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Mirador Therapeutics, Inc.Recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Protagonist Therapeutics, Inc.RecruitingHealthy VolunteerAustralia
Clinical Trials on consumption of maize porridge containing stable iron isotope
-
GlaxoSmithKlineCompleted
-
National Institute of Diabetes and Digestive and...CompletedIron Deficiency AnemiaUnited States
-
Swiss Federal Institute of TechnologyCompletedObesity | Overweight | PregnancySwitzerland
-
Swiss Federal Institute of TechnologyJomo Kenyatta University of Agriculture and Technology; International Centre... and other collaboratorsCompletedAnemia, Iron-DeficiencyKenya
-
Swiss Federal Institute of TechnologyJomo Kenyatta University of Agriculture and Technology; Msambweni County Referral...CompletedAnemia | Iron DeficiencyKenya